BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26444110)

  • 21. Postabortion Initiation of Long-Acting Reversible Contraception by Adolescent and Nulliparous Women in New Zealand.
    Rose SB; Garrett SM
    J Adolesc Health; 2016 Feb; 58(2):160-6. PubMed ID: 26603946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Free-of-charge long-acting reversible contraception: two-year discontinuation, its risk factors, and reasons.
    Saloranta TH; Gyllenberg FK; But A; Gissler M; Laine MK; Heikinheimo O
    Am J Obstet Gynecol; 2020 Dec; 223(6):886.e1-886.e17. PubMed ID: 32562657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends of Contraceptive Choices Among Young Women in Inner City Houston.
    Patel PR; Abacan A; Smith PB
    J Pediatr Adolesc Gynecol; 2019 Oct; 32(5):487-490. PubMed ID: 31125608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health Care Provider Attitudes about the Safety of "Quick Start" Initiation of Long-Acting Reversible Contraception for Adolescents.
    Morgan IA; Zapata LB; Curtis KM; Whiteman MK
    J Pediatr Adolesc Gynecol; 2019 Aug; 32(4):402-408. PubMed ID: 30731216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-acting reversible contraception knowledge, attitudes and use among HIV-infected and -uninfected women and their providers.
    Teodoro N; Fu A; Ohly NT; Shalev N; Matseoane-Peterssen D; Westhoff CL
    Contraception; 2019 Oct; 100(4):269-274. PubMed ID: 31226320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with short interpregnancy interval in women who plan postpartum LARC: a retrospective study.
    Harney C; Dude A; Haider S
    Contraception; 2017 Mar; 95(3):245-250. PubMed ID: 27589883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contraceptive continuation in Hispanic women.
    Werth SR; Secura GM; Broughton HO; Jones ME; Dickey V; Peipert JF
    Am J Obstet Gynecol; 2015 Mar; 212(3):312.e1-8. PubMed ID: 25218956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vital signs: trends in use of long-acting reversible contraception among teens aged 15-19 years seeking contraceptive services—United States, 2005-2013.
    Romero L; Pazol K; Warner L; Gavin L; Moskosky S; Besera G; Loyola Briceno AC; Jatlaoui T; Barfield W;
    MMWR Morb Mortal Wkly Rep; 2015 Apr; 64(13):363-9. PubMed ID: 25856258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with never-use of long-acting reversible contraception among adult reproductive-aged women in Ohio.
    Chakraborty P; Chettri S; Gallo MF; Smith MH; Hood RB; Bessett D; Casterline JB; Norris AH; Turner AN
    Perspect Sex Reprod Health; 2023 Mar; 55(1):38-48. PubMed ID: 36336335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
    Chiles DP; Roberts TA; Klein DA
    Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "I don't know enough to feel comfortable using them:" Women's knowledge of and perceived barriers to long-acting reversible contraceptives on a college campus.
    Hall KS; Ela E; Zochowski MK; Caldwell A; Moniz M; McAndrew L; Steel M; Challa S; Dalton VK; Ernst S
    Contraception; 2016 Jun; 93(6):556-64. PubMed ID: 26879627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familiarity and acceptability of long-acting reversible contraception and contraceptive choice.
    Paul R; Huysman BC; Maddipati R; Madden T
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S884.e1-S884.e9. PubMed ID: 31838124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Availability of long-acting reversible contraceptives in Los Angeles County clinics through a Medicaid state plan amendment program.
    Natavio M; Blotky E; Van Horn CM; Waters C; Ihenacho U; Silverstein E; Cortessis VK; Nelson AL
    Contraception; 2018 Dec; 98(6):471-475. PubMed ID: 30076832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
    Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
    Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Young Age, Nulliparity, and Continuation of Long-Acting Reversible Contraceptive Methods.
    Abraham M; Zhao Q; Peipert JF
    Obstet Gynecol; 2015 Oct; 126(4):823-829. PubMed ID: 26348177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Acting Reversible Contraceptive Placement Among Active-Duty U.S. Army Servicewomen.
    Erickson AK; Nelson DA; Shaw JG; Loftus PD; Kurina LM; Shaw KA
    Obstet Gynecol; 2017 May; 129(5):800-809. PubMed ID: 28383371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Socioeconomic differences persist in use of permanent vs long-acting reversible contraception: An analysis of the National Survey of Family Growth, 2006 to 2010 vs 2015 to 2017.
    Beshar I; So J; Chelvakumar M; Cahill EP; Shaw KA; Shaw JG
    Contraception; 2021 Apr; 103(4):246-254. PubMed ID: 33359509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contraceptive method use in the United States: trends and characteristics between 2008, 2012 and 2014.
    Kavanaugh ML; Jerman J
    Contraception; 2018 Jan; 97(1):14-21. PubMed ID: 29038071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. History of unintended pregnancy and patterns of contraceptive use among racial and ethnic minority women veterans.
    Quinn DA; Sileanu FE; Zhao X; Mor MK; Judge-Golden C; Callegari LS; Borrero S
    Am J Obstet Gynecol; 2020 Oct; 223(4):564.e1-564.e13. PubMed ID: 32142832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Access to long-acting reversible contraception among US publicly funded health centers.
    Bornstein M; Carter M; Zapata L; Gavin L; Moskosky S
    Contraception; 2018 May; 97(5):405-410. PubMed ID: 29253581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.